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Summary Photodynamic therapy (PDT) is a form of cancer treatment based on the destruction of cells by the interaction of light, oxygen and
a photosensitizer. Aminolaevulinic acid (ALA) is the prodrug of the photosensitizer protoporphyrin IX (PpIX). ALA-induced PDT depends on
the rate of cellular synthesis of PpIX, which may vary with cell cycle phase. This study has investigated the relationship between cell cycle
phase, PpIX generation and phototoxicity in synchronized and unsynchronized bladder cancer cells (HT1197). In unsynchronized cells,
relative PpIX fluorescence values (arbitrary units) were significantly different between cell cycle phases after a 1-h ALA incubation
(G, 24.8 ± 0.7; S-phase, 32.7 ± 0.8, P < 0.05; G2 35.4 ± 0.8, P < 0.05). In synchronized cells after a 1 -h ALA incubation, cells in G, produced
less PpIX than those in S-phase or G2 [6.65 ± 1.1 ng per 10 cells compared with 15.5 ± 2.1 (P < 0.05), and 8.1 ± 1.8 ng per 105 cells (not
significant) respectively] and were significantty less sensitive to ALA-induced PDT (% survival, G, 76.2 ± 8.3; S-phase 49.7 ± 4.6, P < 0.05; G2
44.2 ± 2.4, P < 0.05). This differential response in tumour cells may have implications for clinical PDT, resulting in treatment resistance and
possible failure in complete tumour response.
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Photodynamic therapy (PDT) is an anti-cancer therapy that
damages cells bv the generation of reactive oxygen species due to
the interaction of light. oxygen and a photoactive chemical
(Weishaupt et al. 1976). It has been shown to be effective in the
treatment of a wide vanrety of neoplasms including bladder cancer
(Kriegmair et al. 1996) and carcinoma in situ of the bladder
(D' Hallewin and Baert. 1995). oesophageal cancer (Sibille et al.
1995). a vaniety of skin cancers (Dougherty et al, 1978) and gastric
cancer (Hayata et al. 1985). However, there is often a substantial
recurrence rate or incomplete response rate possibly because of
focal areas of under treatment (Hayata et al. 1985). Histological
examination of treated tissues has revealed small islands of viable
cells that may serve as foci for these recurrences (Suzuki et al.
1987). This is thought to be due to inadequate light penetration to
all areas of the cancer, or to resistant cells in areas of hypoxia
(Moan and Sommer, 1985). Intrinsic cellular resistance to PDT
(for example due to effective free radical scavenging) or inade-
quate photosensitizer levels within the cell may also be important
factors.
Aminolaexvulinic acid (ALA) is the prodrug of the photosensi-
tizer protoporphyrin IX (PpIX). After ALA administration, cells
generate PpIX via the haem biosynthetic enzyme system (Berlin et
al, 1956). Sensitivity to ALA-induced PDT depends. in part. on
the PpIX generation rate within the cell. The metabolic activity of
a cell may vary with the phase of the cell cycle (Kaczmarek.
1986). and the activity of cellular enzymes may fluctuate in a cell
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cycle-dependent manner (Churchill and Studzinski. 1970).
Therefore, cells in certain phases of the cell cycle may produce
different amounts of PpIX resulting in differential levels of PDT
sensitivity. Actively proliferating cells produce more PpIX on
incubation with ALA than quiescent cells (Schick et al. 1995).
This may be related to the intracellular availability of iron. with
iron-depleted cells generating PpIX more rapidly (Rittenhouse-
Diakun et al. 1995). S-phase progression can be inhibited by iron
withdrawal (Nocka and Pelus. 1988). possibly because of the iron
requirements of DNA synthetic enzymes such as ribonucleoside
diphosphate reductase. which requires two iron atoms for activity
(Brown et al. 1969). Thus. it might be expected that the iron
requirements of S-phase cells would deplete intracellular stores.
allowing increased production of PpIX. It is known that transferrin
receptor expression on the cell surface is maximal in the G,. S- and
M-phases of the cell cycle (indicating relative iron depletion) and
falls by a factor of 4 during G1 (Necker and Cossman. 1983).
Fukuda et al (1993) studied the relationship between the phase of
the cell cycle and the rates of PpIX generation using an epithelial
cell line and serum withdrawal as a means of inducing cell
synchronization. This study did not demonstrate any significant
differences between cell cycle phases. although a trend towards
higher PpIX production by G, cells was noted.
The variability in PDT sensitivity with the cell cycle may be
analogous to that seen using radiotherapy. Radiotherapy. like PDT.
induces cytotoxicity through the generation of reactive oxygen
species (Hewitt and Wilson. 1959). Both radiotherapy and PDT
are known to cause DNA damage (Gomer. 1980). although PDT
causes fewer DNA strand breaks per effective dose unit than
radiotherapy (Moan et al. 1983). Cells are most sensitive to
radiotherapy during mitosis. late G1 and early S-phase. and are
relatively resistant in late S-phase and early G (Terasima and
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Tolmach, 1963). Cells in G, are also relatively radiosensitive
(Humphrey and Dewey. 1965). Similar effects have been observed
with haematoporphyrin derivative (HPD)-induced PDT, when
cells are least sensitive in early G, and are most sensitive in S-
phase (Christensen et al, 1981).
The aims of this project were, therefore, to determine whether
there is any variation in the rates of PpIX generation between
different cell cycle phases and to investigate whether this is related
to differential PDT sensitivity.
MATERIALS AND METHODS
Cell culture
Human bladder cancer cells (HT1 197. Rasheed et al. 1977) were
obtained from the European Collection of Animal Cell Cultures.
(Porton Down, UK, ECACC). Cells were cultured at 37°C in air
supplemented with 5% carbon dioxide in Dulbecco's modified
Eagle medium (DMEM, Gibco) supplemented with 10% newbom
calf serum (Gibco) and 1% penicillin and streptomycin solution
(10 000 IU ml-' and 10 000 jig ml-', respectively, Gibco).
Cell cycle duration: bromodeoxyuridine (BrdU) pulse
labelling
A modified BrdU pulse-labelling technique was used to determine
cell cycle duration (Dolbeare and Seldon, 1994). BrdU is a thymi-
dine analogue, taken up exclusively by cells in S-phase, which can
then be detected by specific fluorescent-labelled monoclonal anti-
bodies. Exponentially growing cells (2 x 106) were incubated with
10 gm bromodeoxyuridine (Sigma Chemicals, UK) in complete
media for 30 min. The cells were then washed twice in phosphate-
buffered saline (PBS, Sigma Chemicals, UK) and incubated in
complete media without BrdU. At 3-h intervals for 15 h cells were
removed from flasks by trypsinization (trypsin 0.05% and EDTA
0.02%. Gibco) and fixed in 1% paraformaldehyde (Sigma
Chemicals, UK) for 5 min at room temperature. The cells were
then permeabilized in 70% methanol at 4°C for 24 h. DNA was
denatured with 2 M hydrochloric acid with 1 mg ml- pepsin A
(derived from porcine stomach mucosa, Sigma Chemicals, UK)
for 1 h at room temperature. The acid was neutralized with 0.1 M
borax solution (Sigma Chemicals, UK). Cells were incubated with
anti-BrdU antibody (25 jg ml-l monoclonal mouse anti-BrdU.
Dako, UK) for 30 min at 370C followed by a second incubation
with a fluorescein isothiocyanate (FITC) conjugated second anti-
body (7 jg ml-' goat anti-mouse, Caltag Laboratories, CA, USA)
for a further 30 min at 37°C. Cells were washed with PBS with 1%
fetal calf serum (Gibco) between antibody additions to reduce non-
specific antibody binding. Cellular DNA was then labelled with
propidium iodide (PI, 50 jg ml-l, Sigma Chemicals, UK) to which
RNAase (Sigma Chemicals. UK) was added to denature any
double-stranded RNA before being run on the cytometer (Beckton
Dickinson FACSort). Cells were analysed with excitation at
488 nm and emission at 630 (± 22) nm for propidium iodide and
530 (± 30) nm for FITC. Three repeats were performed.
Cell synchronization
This was based on the method of Stein et al (1995). Exponentially
growing cells were treated with complete media containing 2 mm
thymidine (Sigma Chemicals, UK), which inhibits cell cycle
progression for cells in S-phase and blocks entry of further cells
into S-phase. The treatment time corresponded to the total duration
of G. M-phase and G1, as determined by BrdU pulse labelling, to
allow cells in G,. M-phase and GI to accumulate at the GI/S
boundary. The thymidine block was then removed, the cells
washed and replaced in media containing 24 gM deoxycytidine.
which replenishes the nucleotide precursor pools. and incubated
for a time corresponding to the duration of S-phase. Cells previ-
ously blocked in S-phase and those held at the G,/S boundary then
pass through S-phase and into G,. The thymidine block is then
reapplied for the G, + M + G time interval. to allow all cells to
progress to the G,/S boundary but prevent entry into S-phase. On
release of this second block with deoxycytidine. all of the cells
should progress through the cell cycle in a synchronized manner.
To confirm that synchronization had occurred. synchronized cells
were labelled with BrdU. sampled at 3-h intervals and processed
using flow cytometry. This allowed quantification of the propor-
tion of cells in each phase of the cell cycle at different times after
release of the block. The effect of inclusion of I mM ALA (Sigma)
in the culture media of synchronized cells during cell cycle
progression was also studied.
The resultant synchronized DNA histograms were analysed
using a curve-fitting program (ModFit LT. Verity Software House).
which determined the percentage of cells in each phase of the cell
cycle at each time point. (Five repeats of each experiment were
performed.)
PpIX deWmination
This method has been described in a previous publication (Wyld
et al, 1997). In brief, flasks of synchronized cells were obtained
as above. At times corresponding to S-phase. G,/M and G,. cells
were incubated with 1 mm ALA in complete medium for 1 or 4 h.
in the dark, at 37°C. PpIX concentrations in the cells and the media
were then determined by spectrofluorimetry (excitation at 406 nm.
emission at 60(4 nm, Perkin-Elmer LS-3 fluorescence spectrom-
eter). Values were expressed as either ng PpIX per I05 cell or ng
PpIX per jg cellular protein. The cell count was determined using
haemocytometry (Freshney. 1987) and the protein content by the
micro-Lowry method (Lowry et al. 1951). Six triplicate repeats
were performed.
MTT assay
This technique allows quantification of cell survival after a cyto-
toxic insult. MTT (3-(4,5-dimethylthiazol-2yl)-2.5-diphenyl tetra-
zolium bromide, Sigma Chemicals, UK) is metabolized by the
mitochondrial enzyme. lactate dehydrogenase to a violet-coloured
formazan product in direct proportion to the number of cells
present over a predetermined range (Stratford and Stephens.
1989). The optical density of the product is quantified spectro-
photometrically on a 96-well-plate reader. MTT, 0.5 mg ml-l. was
added to each well of a 96-well plate and incubated for 2 h. The
medium was then removed and replaced with 200 jl of dimethyl
sulphoxide (DMSO) (Sigma. UK) to solubilize the fonnazan. The
plate was then read on an ELISA plate reader (Anthos Labtec
Instruments) at 550 nm absorbance. The initial plating density was
determined by plating serial cell dilutions into the wells of a 96-
well plate and comparing the direct haemocytometer count with
the colour density produced. All further experiments used a cell
density within the linear portion of the curve.
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Figure 4 Bivariate histogram of PpIX fluorescence (y-axis) against DNA content (bisbenzamide fluorescence) after a 4-h incubation with ALA
histograms are shown in Figure 1. From these data. the optimal
sampling times for each phase of the cell cycle after release of
the thymidine block were determined. The percentage of BrdU-
labelled cells can also be used as an estimate of the efficiency of
synchronization in the S-phase period of the cell cycle. i.e. the 1-
and 3-h samples. The percentage of BrdU-labelled cells at 1 and 3
h were 71 ± 3.3 and 77 ± 2.8, respectively, suggesting a good level
of cell synchronization. The total cell cycle duration was 15 h. The
4-h ALA treatment times were as follows: S-phase from 1 to 5 h.
G, from 5 to 9 h and GI from 10 to 14 h. Forl-h ALA treatments
the S-phase was from 1 to 2 h. G, from 5 to 6 h and GI from 11 to
12 h. Incubation of cells in media containing 1 mM ALA for the
15-h duration of this experiment had no detectable effect on cell
cycle progression (data not shown).
Protoporphynn IX generation
After incubation of synchronized cells with ALA for 1 h. S-phase
cells produced significantly more intracellular PpIX per 105 cells
than G, or GI cells (15.5 vs 8.1. P < 0.05 and 6.6, P < 0.05 respec-
tively) and significantly more total (cellular plus media PpIX) PpIX
105 cells than G, and GI cells (l7.8 v ll P <0.05 and 9.6.P < 0.05
respectively, Figure 2). When PpIX generation was calculated per
ig of cellular protein, a similar pattern was seen with intracellular
PpIX being significantly greater in S-phase cells than in G, or G,
cells (0.12 vs 0.98, P < 0.05. and 0.1. P < 0.05 respectively).
After a 4-h incubation of synchronized cells with ALA. total
PpIX per 10' cells was significantly less in G, than in G, and S-
phase cells (39.5 vs 56. P < 0.05 and 51. P < 0.05 respectively).
and intracellular PpIX was significantly less in G, than in S-phase
cells (9.5 vs 12.7. P < 0.05 respectively, Figure 2). When PpIX
was calculated per jg of protein after a 4-h incubation with ALA.
no significant differences were noted between cell cycle phases
(data not shown).
PDT sensitivity
After a 1-h incubation with ALA and light administration, cell
survival was greatest in G, cells and least with cells in G, at both
light doses studied (Figure 3). With the 0.5 J cm-2 light dose, G,
survival was significantly greater than G, and S-phase (76.2 vs
44.2. P < 0.05 and 49.7. P < 0.05 respectively). At the higher light
dose no significant differences were observed. After a 4-h incuba-
tion with ALA followed by PDT. no significant difference was
noted between cell cycle phases (data not shown). Controls for
light alone and ALA alone showed no significant toxicity
compared with the no lights no ALA control.
Dual labelling
After a 1-h incubation with ALA and bisbenzimide. DNA
histograms were obtained (mean coefficient of variation of the GI
peak of 10.3 ± 0.9) and PpIX fluorescence was detected. The
bivariate histograms showed the GI cells to have a wider range of
PpIX fluorescence than the other two phases of the cell cycle with
a significantly lower mean (G,. 24.8: S. 32.7; P < 0.05 and G,.
35.4. P < 0.05). After a 4-h incubation with ALA and 1 h with
bisbenzimide, these cell cycle phase differences were similarly
significantly different (G,. 46.5: S-phase. 55.9. P < 0.05: and G,.
65.1. P < 0.05). The PpIX levels were significantly (P <0.05)
greater after a 4 h ALA incubation than after 1 h (55.2 ± 4.7 and
28.1 ± 0.7 respectively). An example of a PpIX/bisbenzamide
histogram is shown in Figure 4 and mean cell cycle-specific PpIX
fluorescence values are shown in Figure 5.
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is a broad range of PpIX fluorescence values, from 10 to 50 (arbi-
trary units), whereas the odter two cycle phases have ranges from 30
to 50. The low fluorescent subpolation of GI may be a PDT-resis-
tant subgroup responsible for the increased percentage suvival of
G1 cells after PDT.
In summary, it is possible that in a homogeneous population of
tumour cells those cells in GI may be relatively insensitive to
ALA-induced PDT (due to both decreased PpIX production and
decreased PDT sensitivity) and thus survive reatment to provide
foci of recurrence. However, there are many other confounding
factors in the in vivo tumour microenvironment that may render
cellular PpIX generation less efficient than in vitro, including
pharmacokinetic bioavailability of ALA, poor tumour vascularity
and hypoxia, which slows the rate of PpIX generation (L Wyld,
unpublished data; Falk et al, 1959). It is also known that some of
the toxicity of PDT may be due to microcirculatory collapse in the
trated tissue, which may damage cells by inducing hypoxia (Reed
et al, 1989), even if they have generated insufficient PpDX to suffer
direct PDT toxicity. If PDT sensitivity, due to cell cycle variation,
is a factor contributing to tumour recurrence, it could be overcome
by the application either of adequate diug and light dosimetry or of
a multiple-treatment regime to ensure cell cycle redistribution and
tumour reoxygenation. This would allow relatively resistant G,
cells to progress through the cell cycle to more sensitive cell cycle
phases before administration of a second dose. At present, no data
are available on whether cell cycle phase variation in PpIX gener-
ation or PDT sensitivity exists in vivo. Further in vivo studies are
needed to validate these in vitro findings.
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